Replication stress induces specific enrichment of RECQ1 at common fragile sites FRA3B and FRA16D
© Lu et al.; licensee BioMed Central Ltd. 2013
Received: 4 February 2013
Accepted: 10 April 2013
Published: 22 April 2013
Stalled replication forks at common fragile sites are a major cause of genomic instability. RecQ helicases, a highly conserved family of DNA-unwinding enzymes, are believed to ease ‘roadblocks’ that pose challenge to replication fork progression. Among the five known RecQ homologs in humans, functions of RECQ1, the most abundant of all, are poorly understood. We previously determined that RECQ1 helicase preferentially binds and unwinds substrates that mimic DNA replication/repair intermediates, and interacts with proteins involved in DNA replication restart mechanisms.
We have utilized chromatin immunoprecipitation followed by quantitative real-time PCR to investigate chromatin interactions of RECQ1 at defined genetic loci in the presence or absence of replication stress. We have also tested the sensitivity of RECQ1-depleted cells to aphidicolin induced replication stress.
RECQ1 binds to the origins of replication in unperturbed cells. We now show that conditions of replication stress induce increased accumulation of RECQ1 at the lamin B2 origin in HeLa cells. Consistent with a role in promoting fork recovery or repair, RECQ1 is specifically enriched at two major fragile sites FRA3B and FRA16D where replication forks have stalled following aphidicolin treatment. RECQ1-depletion results in attenuated checkpoint activation in response to replication stress, increased sensitivity to aphidicolin and chromosomal instability.
Given a recent biochemical observation that RECQ1 catalyzes strand exchange on stalled replication fork structures in vitro, our results indicate that RECQ1 facilitates repair of stalled or collapsed replication forks and preserves genome integrity. Our findings provide the first evidence of a crucial role for RECQ1 at naturally occurring fork stalling sites and implicate RECQ1 in mechanisms underlying common fragile site instability in cancer.
KeywordsRecQ Helicase Replication stress DNA repair DNA damage Genomic instability
Inherited syndromes characterized by the replication defects and genomic instability emphasize that DNA replication and repair must be highly coordinated processes . Deficiencies in DNA replication and repair mechanisms become particularly detrimental at genomic sequences that present unique challenges to the replication fork progression [2, 3]. Common fragile sites (CFS) are specific chromosomal regions, extending over large DNA sequences, which are especially prone to genomic instability under conditions of replication stress [4, 5]. At fragile sites, under conditions of replication stress, the replicative polymerases may uncouple from the helicase, resulting in long regions of single-stranded DNA ahead of polymerase that could pose fork barriers leading to fork disassembly and DNA breaks [5, 6]. CFS are expressed as site-specific gaps or breaks on metaphase chromosomes after partial inhibition of DNA synthesis, and exhibit sister chromatid exchange (SCE), deletions and translocations . Thus, CFS serve as genomic hot spots for DNA damage and carcinogenesis .
Members of RecQ family DNA helicases, represented by five homologs (BLM, WRN, RecQ4, RecQ5β and RECQ1) in humans, are implicated in genome maintenance through repair of stalled or collapsed replication forks [8, 9]. RecQ helicases are specifically recruited to the sites of arrested DNA replication where in addition to serving repair functions, they help stabilize stalled replication complexes and likely contribute to the S-phase checkpoints [10–14]. Importantly, WRN, defective in the premature aging disease Werner syndrome, has been shown to regulate fragile site stability . WRN helicase activity and ATR-mediated checkpoint response collaborate in a common pathway to maintain CFS stability and WRN-deficiency is associated with accumulation of gaps and breaks at CFS [13, 15]. In vitro, WRN enhances human DNA polymerase δ-dependent DNA synthesis through secondary structure forming sequences within the FRA16D fragile site . Functions of BLM, defective in the cancer predisposition disease Bloom syndrome, are especially important for cells in dealing with replication stress . WRN and BLM likely perform distinct functions in recovery from fork stalling genome-wide , and collective literature points to their significant roles in maintaining genomic stability at CFS. Loss of BLM induces 53BP1 nuclear bodies that guard chromosomal fragile sites against genomic instability . Furthermore, BLM associates with the ultrafine DNA bridges that interlink sister chromatids at CFS loci and is required for their resolution . In fact, human RecQ homologs exhibit diverse catalytic activities relevant to replication restart pathways including disruption of Rad51 presynaptic filament (BLM and RecQ5β) [20, 21], dissolution of double Holliday junctions (BLM) [22, 23], branch migration of Holliday junctions (BLM, WRN and RECQ1) [24–26] dissociation of mobile D-loops (BLM, RECQ1 and WRN) [23, 27, 28], and annealing of complementary single strand DNA (all five) [29–33]. Functions of RecQ helicases are therefore likely to be critical under replication stress; among these, the roles of WRN and BLM remain best characterized while there is only limited information available for other RecQ proteins.
RECQ1 (also known as RECQL or RECQL1), the most abundant of the five human RecQ proteins, was recently identified as an integral component of replication complex in unperturbed cells and implicated in maintaining replication fork progression after initiation . Indeed, recombinant RECQ1 binds and unwinds model replication forks and DNA structure intermediates of recombination . Most recently, RECQ1, similar to WRN, was also shown to promote strand exchange on synthetic stalled replication fork-mimicking structures in vitro . Depletion of RECQ1 reduces cell proliferation and RECQ1-deficient cells accumulate DNA damage, display heightened sensitivity to DNA damaging agents that induce stalled and collapsed replication forks, and exhibit chromosomal instability [36–38]. Evidently, RECQ1-deficient cells are characterized by spontaneous Rad51 foci and elevated SCEs  reminiscent of recombinogenic structures proposed to arise upon replication fork restart following collapse . To investigate a role of RECQ1 in replication fork maintenance, we employed quantitative chromatin immunoprecipitation (ChIP) and examined in vivo chromatin interactions of RECQ1 in cycling cells following replication inhibition with hydroxyurea or aphidicolin. We report specific binding of RECQ1 to two major fragile sites, FRA3B and FRA16D, in aphidicolin treated HeLa cells. Our results provide novel evidence and complement existing biochemical data for a role of RECQ1 in genome maintenance upon replication stress.
The cellular phenotypes of RECQ1-deficiency and biochemical data suggest a role of RECQ1 in mechanisms involved in replication stress response. To investigate a role of RECQ1 in the repair of stalled or collapsed replication forks, we have evaluated chromatin interaction of RECQ1 at specific genomic loci in cells exposed to replication blocking agents.
Recruitment of RECQ1 to lamin B2 origin is selectively enhanced upon replication stress
RECQ1 protein is expressed throughout the cell cycle and is not regulated in cell cycle stage specific manner ; although a small increase is reported in T98G cells synchronized in S-phase using serum starvation or mimosine treatment . We monitored cell cycle progression in HeLa cells utilized in ChIP assay by FACS analysis (Figure 1D) and also determined total cellular RECQ1 protein level (Figure 1E). Total RECQ1 protein level was not modulated appreciably in HeLa cells following treatment with hydroxyurea or aphidicolin (Figure 1E). We next examined cellular RECQ1 in chromatin containing fractions following treatment with agents that introduce replication fork blocking lesions. HeLa cells either untreated or treated with hydroxyurea (2 mM, 24 h) or aphidicolin (0.5 μM, 24 h) were subjected to detergent extraction to isolate insoluble nuclear pellet containing proteins that were tightly bound to chromatin and/or nuclear matrix. RECQ1 protein in untreated cells predominantly fractionated with soluble proteins and only a minor fraction associated with chromatin in the insoluble nuclear pellet (Figure 1F). Interruption of DNA synthesis by hydroxyurea or aphidicolin resulted in increased RECQ1 in the insoluble fraction that also contained histones (Figure 1F). Apparently, increased chromatin association of RECQ1 was also seen following treatment with the DNA inter-strand crosslinking agent mitomycin C (0.5 μg/ml, 24 h) that induces double strand breaks on encounter with progressing replication fork (Figure 1F). When replication fork progression was inhibited by incubating the cells with aphidicolin prior to mitomycin C treatment, chromatin-bound RECQ1 signal was reduced as compared to mitomycin C alone but was greater than the untreated cells (Figure 1F). Thus, stalled and collapsed replication forks induce re-localization of endogenous RECQ1 to the chromatin.
Aphidicolin treatment induces RECQ1 enrichment at CFS
Collectively, these experiments demonstrate preferential and specific binding of RECQ1 to the two well characterized aphidicolin-sensitive fragile sites FRA3B and FRA16D in response to replication stress.
RECQ1-depleted cells show aphidicolin sensitivity, defective response to replication stress, and chromosomal fragility
Increased sensitivity to genotoxic agents may be caused not only by defects in DNA repair but also by disruption of cell cycle checkpoint responses to DNA damage . ATR-dependent Chk1 phosphorylation is induced to stabilize replication complexes on stalled forks in cells treated with aphidicolin or hydroxyurea and the RPA coated single-stranded DNA is considered to be the predominant signal for activation of the ATR-Chk1 signal transduction pathway . We examined by Western blotting Chk1 phosphorylation at Ser317 that is central to the normal DNA damage response to replication stress . As compared to control siRNA transfected cells, RECQ1-depleted HeLa cells exhibit constitutively activated Chk1 as shown by phosphorylation at Ser317 in the absence of exogenously induced stress (Figure 4C). Appearance of RPA32 phosphorylation in undamaged RECQ1-depleted cells suggests that the checkpoint response is triggered by DNA structures generated during replication such as collapsed replication forks, long stretches of single-stranded DNA, or unresolved complex intermediates in RECQ1-deficiency. Pharmacological induction of replication stress revealed aberrant checkpoint activation in RECQ1-depleted cells (Figure 4C). Hydroxyurea treatment (2 mM, 24 h) resulted in the phosphorylation of Chk1 at Ser317 and RPA32 in control siRNA transfected HeLa cells (Figure 4C). In contrast, hydroxyurea treatment of RECQ1-depleted cells displayed consistently attenuated phosphorylation of Chk1 at Ser317 and reduced RPA32 phosphorylation (Figure 4C). Reduced Chk1 phosphorylation was also observed in response to aphidicolin treatment (0.5 μM, 24 h) in RECQ1-depleted cells as compared to control HeLa cells (Figure 4C). RPA32 phosphorylation was not evident in control HeLa cells upon arresting replication with aphidicolin  and a minimal increase in the signal for RPA phosphorylation was seen in RECQ1-depleted cells as compared to their untreated condition (Figure 4C). We observed a modest increase in signal for γH2AX in untreated and aphidicolin treated RECQ1-depleted cells as compared to control siRNA transfected cells (Figure 4C).
Partial inhibition of DNA synthesis by aphidicolin results in incomplete replication in late replicating chromosomal areas such as fragile sites leading to visible breaks in metaphase chromosomes . We therefore examined whether RECQ1-depletion increases the basal and aphidicolin-induced metaphase chromosome breaks. Depletion of RECQ1 led to a significant increase in the number of chromosome breaks per cell even in the absence of aphidicolin when compared to the control siRNA (Figure 4D). This is consistent with spontaneous chromosome breaks and gaps observed in RECQ1 knockout mouse embryonic fibroblasts  and a recent report using stable knockdown of RECQ1 in human cells .
Given the demonstrated ability of RECQ1 to act upon replication fork like structures in vitro [33, 35], these results indicate that depletion of RECQ1 as such may contribute to replication fork collapse and also diminish recovery from replication arrest.
Here we show that conditions of replication stress, specifically aphidicolin-induced DNA polymerase α, δ and inhibition, and hydroxyurea-mediated inhibition of ribonucleotide reductase, induce a preferential accumulation of RECQ1 at the lamin B2 origin in HeLa cells. Consistent with a role in promoting fork recovery or repair, we find that RECQ1 is enriched at two major fragile sites, FRA3B and FRA16D, where replication forks have stalled following aphidicolin treatment. Moreover, RECQ1-depletion results in diminished checkpoint activation in response to replication stress, increased sensitivity to aphidicolin and chromosomal instability. These results suggest that RECQ1 is important for maintaining genomic integrity when DNA replication forks are slowed by hydroxyurea or aphidicolin and promote efficient recovery from replication stress.
Results from Thangavel et al proposed that RECQ1 is assembled at origins at the start of bidirectional replication and is subsequently lost from the origin perhaps still tracking along with the newly formed replisome following origin firing . Consistent with this, we found a significant enrichment of RECQ1 at origins when replication fork progression was inhibited by treatment with hydroxyurea or aphidicolin. Furthermore, our ChIP data show differential recruitment of RECQ1 at the lamin B2 origin in response to treatment with aphidicolin (about 30-fold) or hydroxyurea (about 11-fold). Aphidicolin has been shown to have little effect on the activation or initiation of replication origins and induces uncoupling of replication machinery ; it is likely that RECQ1 recognizes the long stretch of single-stranded DNA produced due to functional uncoupling of the replicative polymerase and helicase complexes following aphidicolin treatment. Indeed, we found that endogenous RECQ1 displays preferential binding to CFS as compared to non-fragile control DNA especially after cells are treated with aphidicolin. CFS represent single-stranded unreplicated chromosomal regions caused by stalled or collapsed replication forks . This notion has been substantiated by investigation of replication timing  and the evidence of involvement of checkpoint proteins ATR [59, 60], BRCA1 , SMC1  and FANCD2  in fragile site stability. Additionally, CFS sequences including FRA16D are characterized by high AT content, AT-rich mini satellite repeats and their tendency to form secondary structures . Human RecQ proteins have demonstrated ability to resolve a variety of non-B DNA secondary structures . It is yet unknown whether RECQ1, like WRN , can resolve the predicted cruciform structures at FRA16D that stall replication fork progression and contribute to chromosome breakage; however, the fact that RECQ1 was also enriched at FRA3B that is devoid of mini- or microsatellite  indicates that the secondary structures alone may not be a sufficient structural element for RECQ1 binding to the fragile sites. WRN functions at fragile sites are critical but it has not yet been shown whether WRN is recruited to the fragile site loci in vivo, and whether it can distinguish fragile and non-fragile regions under replication stress. RecQ proteins are known to form multi-protein complexes to execute their functions [14, 66], and it is conceivable that yet unknown protein partners of RECQ1 recruit and/or mediate its functions at stalled and broken forks at fragile site loci and elsewhere in the genome.
Stalled replication fork activates checkpoint signaling pathways to coordinate cell cycle progression with repair of damage, ensuring the integrity of the genome [52, 67]. ATR and Chk1-dependent checkpoints prevent excessive formation of DNA double strand breaks during replication arrest . RPA protein complex, consisting of three subunits RPA72, RPA32 and RPA14, is a first sensor of replication-associated damage and is thought to signal activation of ATR and thereby trigger an intra-S checkpoint . Depletion of RECQ1 led to spontaneous phosphorylation of RPA32 and activation of Chk1; however, RECQ1-depleted cells are defective in triggering replication stress response and exhibit sensitivity to replication blocking agents . During normal DNA replication, optimal binding of RECQ1 to the origins may ensure appropriate and accurate genome duplication during S-phase. Loss of RECQ1 leads to aberrant elongation of progressing replication forks  which may lead to activate the checkpoint response. The fork promoting activity of RECQ1 could be especially important at naturally occurring DNA sequences such as fragile sites that are at increased risk for stalling the replication fork even in the absence of external replication stress. Our data implicate that RECQ1 also participates in relaying signals of fork stalling that help coordinate a faithful cell cycle and recovery from replication stress. RECQ1 may contribute to mutational avoidance in unperturbed and deliberately stalled replication.
Chromosome breaks observed upon acute depletion of RECQ1 is consistent with a recent finding that depletion of RECQ1 activates DNA damage signaling cascade and accumulates replication-induced double strand breaks . Conditions that slow replication along the entire genome, such as aphidicolin treatment, lead to double strand break formation as a result of fork stalling and collapse at fragile sites and activate the double strand break repair pathways . Homologous recombination is a major mechanism utilized to repair stalled or collapsed replication forks . Importantly, homologous recombination mechanisms triggered by replication arrest differ from those involved in repairing classical two ended DNA double strand breaks . Thus, although the repair of I-Sce induced double strand break was not significantly modulated by RECQ1-deficiency , a role for RECQ1 in recombination repair of replication-induced double strand breaks remains possible. In vitro activity of RECQ1 to unwind synthetic replication fork and catalyze strand exchange indicates its potential ability to form and subsequently branch migrate Holliday junction like recombination structures generated during template switching at the stalled forks [35, 71]. It is conceivable that in the absence of RECQ1, recombinogenic DNA structures at arrested forks are repaired via homologous recombination.
Fragile loci often coincide with chromosomal breakpoints in tumors [5, 72]. Given the elevated proliferation status of tumor cells, proteins involved in the cellular response to replication stress are likely to act as caretakers of the genome during tumor development . A mutation in RECQ1 has not been linked to a human disease yet, but an Oncomine database search shows that RECQ1 is over-expressed in many clinical cancer samples compared to matched normal samples (Additional file 1: Figure S1). Similar trend of RECQ1 over-expression across various tumors is presented by another web database search (http://medicalgenome.kribb.re.kr/GENT/). It is plausible that cancer cells position RECQ1 on to specific genomic loci so as to cope with increased replication-mediated DNA damage during rapid cell division; in normal cells, RECQ1 can act as a tumor suppressor by facilitating DNA repair and preventing mutations. This notion is consistent with the observation that RECQ1 is uniquely important for the proliferation of cancer cells [37, 40, 41]. DNA breakage within CFS is thought to be a consequence of failing to complete replication and/or resolving the arrested forks prior to the end of telophase and chromosome segregation . Recent reports have also suggested that chromosomal breaks occur at fragile sites because these loci are late replicating and origin poor [73–75]. Whether chromosomal breaks in RECQ1-deficient cells occur at CFS remains to be examined, but recruitment of RECQ1 at FRA3B and FRA16D suggests that RECQ1 either prevents replication fork stalling within origin poor regions or resolves replication problems at these CFS. Future experiments will examine what functional sub-modules of DNA replication are associated with RECQ1 at specific genomic loci and how it participates in dynamic response to challenges during DNA replication. Present findings together with the in vitro results indicate that impaired response to replication stress contributes to genomic instability in RECQ1-deficient cells.
RECQ1, to our knowledge, is the first human RecQ helicase shown to bind CFS. Overall, our results provide new insight to RECQ1 functions and contribute to dissecting unique and overlapping roles of human RecQ homologs in facilitating replication fork progression through natural impediments in genome.
Note added in proof: While this work was under review, a study by Berti et al. also reported a role of RECQ1 in replication fork restart .
Materials and methods
Cell culture, drug treatment and siRNA transfection
Human HeLa (ATCC) were grown in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen) supplemented with 10% fetal bovine serum (Hyclone Laboratories), 100 U/ml penicillin and 100 μg/ml streptomycin (Invitrogen). Cells were grown in a humidified 5% CO2 incubator at 37°C. To induce replication stress, exponentially growing cells were treated with hydroxyurea (Sigma), aphidicolin (Calbiochem), mitomycin C (Sigma) as indicated. Depletion of RECQ1 was achieved by transfecting HeLa cells with a scrambled control siRNA or a SMARTpool of four distinct siRNA species targeting different regions of RECQ1 mRNA (siGenome SMARTpool, Dharmacon) at a final concentration of 10 nM using Lipofectamine 2000 transfection reagent as per the manufacturer’s instructions (Invitrogen). Knockdown specificity and efficacy of RECQ1 smartpool siRNA was evaluated by real-time PCR and Western blotting.
Chromatin immunoprecipitation (ChIP)
Primers used for quantitative real-time PCR analyses
Cells were collected by trypsinization and fixed with 70% ethanol for 30 min. Cells were subsequently washed in PBS, treated with RNase in PBS, and resuspended in PBS with 4 μg/ml propidium iodide. Cells were analyzed on a FACSCalibur™ flow cytometer from BD Science using ModFit LT software.
Biochemical fractionation and Western blotting
Chromatin enriched fractions were prepared as previously described  from cells that were either untreated or treated with indicated concentration of hydroxyurea or aphidicolin. To obtain total extracts, cells were lysed in RIPA buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) containing cocktail of protease and phosphatase inhibitors (Roche). Equal amounts of total protein for each sample was run on 8-16% SDS-PAGE and transferred to PVDF membrane for immunoblotting with antibodies for phospho-Chk1 Ser 317 (Cell Signaling, 2344), γH2AX (Cell Signaling, 2577), RPA32 (Bethyl Lab, A300-244A), RECQ1 (Bethyl Lab, A300-450A), GAPDH (Cell Signaling, 2118), and Histone H3 (Cell Signaling, 4499); all antibodies were used at 1:1000 dilution.
Cell proliferation assay
Cells (24 h after siRNA transfection) were seeded in quadruplicate at a density of 3000 cells/well in 96-well plates and allowed to adhere for 16 h and subsequently exposed to increasing concentration of aphidicolin (0-5 μM) and allowed to grow at 37°C for 3 days in 5% CO2. Cell proliferation was determined by CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay (MTS) (Promega). Additionally, cells were transfected with the indicated siRNA, split 1:4 onto a multiwell plate, and grown in the presence or absence of aphidicolin for further 72 h. The cells in one well were counted every 24 h for the duration of the experiment.
Metaphase chromosome analyses
Cells, 48 h after transfection, were grown in the presence or absence of aphidicolin (0.5 μM) for 24 h and treated with 0.5 μg/ml colchicine for 4 h at 37°C before collection. To prepare metaphase spreads, cells were resuspended in hypotonic solution (0.06 M KCl) for 15 min at room temperature, and then fixed with 3:1 (vol/vol) methanol-glacial acetic acid. Fixed cell suspension was dropped onto precleaned microscope slides and air-dried overnight. Metaphase chromosomes were visualized by Giemsa staining. Images were documented with a Nikon microscope and at least 10 metaphase chromosome spreads per treatment were scored in a blinded fashion.
Flow cytometry was performed at the NCI core facility. This work was funded by the NIGMS/NIH grant 5SC1GM093999-04 to SS. We acknowledge infrastructure support from the NIMHD/NIH under award number G12MD007597. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
- Jackson SP, Bartek J: The DNA-damage response in human biology and disease. Nature. 2009, 461: 1071-1078. 10.1038/nature08467PubMed CentralView ArticlePubMed
- Mirkin EV, Mirkin SM: Replication fork stalling at natural impediments. Microbiol Mol Biol Rev. 2007, 71: 13-35. 10.1128/MMBR.00030-06PubMed CentralView ArticlePubMed
- Aguilera A, Gomez-Gonzalez B: Genome instability: a mechanistic view of its causes and consequences. Nat Rev Genet. 2008, 9: 204-217. 10.1038/nrg2268View ArticlePubMed
- Freudenreich CH: Chromosome fragility: molecular mechanisms and cellular consequences. Front Biosci. 2007, 12: 4911-4924. 10.2741/2437View ArticlePubMed
- Durkin SG, Glover TW: Chromosome fragile sites. Annu Rev Genet. 2007, 41: 169-192. 10.1146/annurev.genet.41.042007.165900View ArticlePubMed
- Debatisse M, Le Tallec B, Letessier A, Dutrillaux B, Brison O: Common fragile sites: mechanisms of instability revisited. Trends Genet. 2012, 28: 22-32. 10.1016/j.tig.2011.10.003View ArticlePubMed
- Ozeri-Galai E, Bester AC, Kerem B: The complex basis underlying common fragile site instability in cancer. Trends Genet. 2012, 28: 295-302. 10.1016/j.tig.2012.02.006View ArticlePubMed
- Bachrati CZ, Hickson ID: RecQ helicases: guardian angels of the DNA replication fork. Chromosoma. 2008, 117: 219-233. 10.1007/s00412-007-0142-4View ArticlePubMed
- Bernstein KA, Gangloff S, Rothstein R: The RecQ DNA helicases in DNA repair. Annu Rev Genet. 2010, 44: 393-417. 10.1146/annurev-genet-102209-163602PubMed CentralView ArticlePubMed
- Hunter N: The RecQ DNA helicases: Jacks-of-all-trades or master-tradesmen?. Cell Res. 2008, 18: 328-330. 10.1038/cr.2008.33View ArticlePubMed
- Monnat RJ: Human RECQ helicases: roles in DNA metabolism, mutagenesis and cancer biology. Semin Cancer Biol. 2010, 20: 329-339. 10.1016/j.semcancer.2010.10.002PubMed CentralView ArticlePubMed
- Chu WK, Hickson ID: RecQ helicases: multifunctional genome caretakers. Nat Rev Cancer. 2009, 9: 644-654. 10.1038/nrc2682View ArticlePubMed
- Pichierri P, Ammazzalorso F, Bignami M, Franchitto A: The Werner syndrome protein: linking the replication checkpoint response to genome stability. Aging (Albany NY). 2011, 3: 311-318.
- Brosh RM, Bohr VA: Human premature aging, DNA repair and RecQ helicases. Nucleic Acids Res. 2007, 35: 7527-7544. 10.1093/nar/gkm1008PubMed CentralView ArticlePubMed
- Pirzio LM, Pichierri P, Bignami M, Franchitto A: Werner syndrome helicase activity is essential in maintaining fragile site stability. J Cell Biol. 2008, 180: 305-314. 10.1083/jcb.200705126PubMed CentralView ArticlePubMed
- Shah SN, Opresko PL, Meng X, Lee MY, Eckert KA: DNA structure and the Werner protein modulate human DNA polymerase delta-dependent replication dynamics within the common fragile site FRA16D. Nucleic Acids Res. 2010, 38: 1149-1162. 10.1093/nar/gkp1131PubMed CentralView ArticlePubMed
- Sidorova JM, Kehrli K, Mao F, Monnat R: Distinct functions of human RECQ helicases WRN and BLM in replication fork recovery and progression after hydroxyurea-induced stalling. DNA Repair (Amst). 2013, 12: 128-139. 10.1016/j.dnarep.2012.11.005.View Article
- Lukas C, Savic V, Bekker-Jensen S, Doil C, Neumann B, Solvhoj Pedersen R, Grofte M, Chan KL, Hickson ID, Bartek J, Lukas J: 53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress. Nat Cell Biol. 2011, 13: 243-253. 10.1038/ncb2201View ArticlePubMed
- Chan KL, Palmai-Pallag T, Ying S, Hickson ID: Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. Nat Cell Biol. 2009, 11: 753-760. 10.1038/ncb1882View ArticlePubMed
- Bugreev DV, Yu X, Egelman EH, Mazin AV: Novel pro- and anti-recombination activities of the Bloom's syndrome helicase. Genes Dev. 2007, 21: 3085-3094. 10.1101/gad.1609007PubMed CentralView ArticlePubMed
- Hu Y, Raynard S, Sehorn MG, Lu X, Bussen W, Zheng L, Stark JM, Barnes EL, Chi P, Janscak P: RECQL5/Recql5 helicase regulates homologous recombination and suppresses tumor formation via disruption of Rad51 presynaptic filaments. Genes Dev. 2007, 21: 3073-3084. 10.1101/gad.1609107PubMed CentralView ArticlePubMed
- Wu L, Hickson ID: The Bloom's syndrome helicase suppresses crossing over during homologous recombination. Nature. 2003, 426: 870-874. 10.1038/nature02253View ArticlePubMed
- Bachrati CZ, Borts RH, Hickson ID: Mobile D-loops are a preferred substrate for the Bloom's syndrome helicase. Nucleic Acids Res. 2006, 34: 2269-2279. 10.1093/nar/gkl258PubMed CentralView ArticlePubMed
- Constantinou A, Tarsounas M, Karow JK, Brosh RM, Bohr VA, Hickson ID, West SC: Werner's syndrome protein (WRN) migrates Holliday junctions and co-localizes with RPA upon replication arrest. EMBO Rep. 2000, 1: 80-84. 10.1093/embo-reports/kvd004PubMed CentralView ArticlePubMed
- Karow JK, Constantinou A, Li JL, West SC, Hickson ID: The Bloom's syndrome gene product promotes branch migration of holliday junctions. Proc Natl Acad Sci U S A. 2000, 97: 6504-6508. 10.1073/pnas.100448097PubMed CentralView ArticlePubMed
- Mazina OM, Rossi MJ, Deakyne JS, Huang F, Mazin AV: Polarity and Bypass of DNA Heterology during Branch Migration of Holliday Junctions by Human RAD54, BLM, and RECQ1 Proteins. J Biol Chem. 2012, 287: 11820-11832. 10.1074/jbc.M112.341347PubMed CentralView ArticlePubMed
- Bugreev DV, Brosh RM, Mazin AV: RECQ1 possesses DNA branch migration activity. J Biol Chem. 2008, 283: 20231-20242. 10.1074/jbc.M801582200PubMed CentralView ArticlePubMed
- Opresko PL, Sowd G, Wang H: The Werner syndrome helicase/exonuclease processes mobile D-loops through branch migration and degradation. PLoS One. 2009, 4: e4825- 10.1371/journal.pone.0004825PubMed CentralView ArticlePubMed
- Cheok CF, Wu L, Garcia PL, Janscak P, Hickson ID: The Bloom's syndrome helicase promotes the annealing of complementary single-stranded DNA. Nucleic Acids Res. 2005, 33: 3932-3941. 10.1093/nar/gki712PubMed CentralView ArticlePubMed
- Garcia PL, Liu Y, Jiricny J, West SC, Janscak P: Human RECQ5beta, a protein with DNA helicase and strand-annealing activities in a single polypeptide. EMBO J. 2004, 23: 2882-2891. 10.1038/sj.emboj.7600301PubMed CentralView ArticlePubMed
- Machwe A, Lozada EM, Xiao L, Orren DK: Competition between the DNA unwinding and strand pairing activities of the Werner and Bloom syndrome proteins. BMC Mol Biol. 2006, 7: 1- 10.1186/1471-2199-7-1PubMed CentralView ArticlePubMed
- Macris MA, Krejci L, Bussen W, Shimamoto A, Sung P: Biochemical characterization of the RECQ4 protein, mutated in Rothmund-Thomson syndrome. DNA Repair (Amst). 2006, 5: 172-180. 10.1016/j.dnarep.2005.09.005.View Article
- Sharma S, Sommers JA, Choudhary S, Faulkner JK, Cui S, Andreoli L, Muzzolini L, Vindigni A, Brosh RM: Biochemical analysis of the DNA unwinding and strand annealing activities catalyzed by human RECQ1. J Biol Chem. 2005, 280: 28072-28084. 10.1074/jbc.M500264200View ArticlePubMed
- Thangavel S, Mendoza-Maldonado R, Tissino E, Sidorova JM, Yin J, Wang W, Monnat RJ, Falaschi A, Vindigni A: Human RECQ1 and RECQ4 helicases play distinct roles in DNA replication initiation. Mol Cell Biol. 2010, 30: 1382-1396. 10.1128/MCB.01290-09PubMed CentralView ArticlePubMed
- Popuri V, Croteau DL, Brosh RM, Bohr VA: RECQ1 is required for cellular resistance to replication stress and catalyzes strand exchange on stalled replication fork structures. Cell Cycle. 2012, 11: 4252-4265. 10.4161/cc.22581PubMed CentralView ArticlePubMed
- Sharma S, Stumpo DJ, Balajee AS, Bock CB, Lansdorp PM, Brosh RM, Blackshear PJ: RECQL, a member of the RecQ family of DNA helicases, suppresses chromosomal instability. Mol Cell Biol. 2007, 27: 1784-1794. 10.1128/MCB.01620-06PubMed CentralView ArticlePubMed
- Sharma S, Brosh RM: Human RECQ1 is a DNA damage responsive protein required for genotoxic stress resistance and suppression of sister chromatid exchanges. PLoS One. 2007, 2: e1297. 10.1371/journal.pone.0001297PubMed CentralView ArticlePubMed
- Sharma S, Brosh RM: Unique and important consequences of RECQ1 deficiency in mammalian cells. Cell Cycle. 2008, 7: 989-1000. 10.4161/cc.7.8.5707PubMed CentralView ArticlePubMed
- Helleday T: Pathways for mitotic homologous recombination in mammalian cells. Mutat Res. 2003, 532: 103-115. 10.1016/j.mrfmmm.2003.08.013View ArticlePubMed
- Futami K, Kumagai E, Makino H, Goto H, Takagi M, Shimamoto A, Furuichi Y: Induction of mitotic cell death in cancer cells by small interference RNA suppressing the expression of RecQL1 helicase. Cancer Sci. 2008, 99: 71-80.PubMed
- Mendoza-Maldonado R, Faoro V, Bajpai S, Berti M, Odreman F, Vindigni M, Ius T, Ghasemian A, Bonin S, Skrap M: The human RECQ1 helicase is highly expressed in glioblastoma and plays an important role in tumor cell proliferation. Mol Cancer. 2011, 10: 83- 10.1186/1476-4598-10-83PubMed CentralView ArticlePubMed
- Abdurashidova G, Danailov MB, Ochem A, Triolo G, Djeliova V, Radulescu S, Vindigni A, Riva S, Falaschi A: Localization of proteins bound to a replication origin of human DNA along the cell cycle. EMBO J. 2003, 22: 4294-4303. 10.1093/emboj/cdg404PubMed CentralView ArticlePubMed
- Petermann E, Orta ML, Issaeva N, Schultz N, Helleday T: Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol Cell. 2010, 37: 492-502. 10.1016/j.molcel.2010.01.021PubMed CentralView ArticlePubMed
- Sneeden JL, Loeb LA: Mutations in the R2 Subunit of Ribonucleotide Reductase That Confer Resistance to Hydroxyurea. J Biol Chem. 2004, 279: 40723-40728. 10.1074/jbc.M402699200View ArticlePubMed
- Ikegami S, Taguchi T, Ohashi M, Oguro M, Nagano H, Mano Y: Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-[alpha]. Nature. 1978, 275: 458-460. 10.1038/275458a0View ArticlePubMed
- Cheng CH, Kuchta RD: DNA polymerase epsilon: aphidicolin inhibition and the relationship between polymerase and exonuclease activity. Biochemistry. 1993, 32: 8568-8574. 10.1021/bi00084a025View ArticlePubMed
- Sharma S, Phatak P, Stortchevoi A, Jasin M, Larocque JR: RECQ1 plays a distinct role in cellular response to oxidative DNA damage. DNA Repair (Amst). 2012, 11: 537-549. 10.1016/j.dnarep.2012.04.003.View Article
- Kawabe T, Tsuyama N, Kitao S, Nishikawa K, Shimamoto A, Shiratori M, Matsumoto T, Anno K, Sato T, Mitsui Y: Differential regulation of human RecQ family helicases in cell transformation and cell cycle. Oncogene. 2000, 19: 4764-4772. 10.1038/sj.onc.1203841View ArticlePubMed
- Ginjala V, Nacerddine K, Kulkarni A, Oza J, Hill SJ, Yao M, Citterio E, van Lohuizen M, Ganesan S: BMI1 Is Recruited to DNA Breaks and Contributes to DNA Damage-Induced H2A Ubiquitination and Repair. Mol Cell Biol. 2011, 31: 1972-1982. 10.1128/MCB.00981-10PubMed CentralView ArticlePubMed
- Wang L, Paradee W, Mullins C, Shridhar R, Rosati R, Wilke CM, Glover TW, Smith DI: Aphidicolin-Induced FRA3B Breakpoints Cluster in Two Distinct Regions. Genomics. 1997, 41: 485-488. 10.1006/geno.1997.4690View ArticlePubMed
- Ramos D, Aldaz CM: WWOX, a chromosomal fragile site gene and its role in cancer. Adv Exp Med Biol. 2006, 587: 149-159. 10.1007/978-1-4020-5133-3_14View ArticlePubMed
- Branzei D, Foiani M: The checkpoint response to replication stress. DNA Repair (Amst). 2009, 8: 1038-1046. 10.1016/j.dnarep.2009.04.014.View Article
- Choi J-H, Lindsey-Boltz LA, Kemp M, Mason AC, Wold MS, Sancar A: Reconstitution of RPA-covered single-stranded DNA-activated ATR-Chk1 signaling. Proc Natl Acad Sci. 2010, 107: 13660-13665. 10.1073/pnas.1007856107PubMed CentralView ArticlePubMed
- Paulsen RD, Cimprich KA: The ATR pathway: fine-tuning the fork. DNA Repair (Amst). 2007, 6: 953-966. 10.1016/j.dnarep.2007.02.015.View Article
- Liu JS, Kuo SR, Melendy T: Comparison of checkpoint responses triggered by DNA polymerase inhibition versus DNA damaging agents. Mutat Res. 2003, 532: 215-226. 10.1016/j.mrfmmm.2003.08.018View ArticlePubMed
- Arlt MF, Durkin SG, Ragland RL, Glover TW: Common fragile sites as targets for chromosome rearrangements. DNA Repair (Amst). 2006, 5: 1126-1135. 10.1016/j.dnarep.2006.05.010.View Article
- Gorisch SM, Sporbert A, Stear JH, Grunewald I, Nowak D, Warbrick E, Leonhardt H, Cardoso MC: Uncoupling the replication machinery: replication fork progression in the absence of processive DNA synthesis. Cell Cycle. 2008, 7: 1983-1990. 10.4161/cc.7.13.6094View ArticlePubMed
- Le Beau MM, Rassool FV, Neilly ME, Espinosa R, Glover TW, Smith DI, McKeithan TW: Replication of a Common Fragile Site, FRA3B, Occurs Late in S Phase and is Delayed Further Upon Induction: Implications for the Mechanism of Fragile Site Induction. Hum Mol Genet. 1998, 7: 755-761. 10.1093/hmg/7.4.755View ArticlePubMed
- Casper AM, Nghiem P, Arlt MF, Glover TW: ATR regulates fragile site stability. Cell. 2002, 111: 779-789. 10.1016/S0092-8674(02)01113-3View ArticlePubMed
- Wan C, Kulkarni A, Wang YH: ATR Preferentially Interacts with Common Fragile Site FRA3B and the Binding Requires its Kinase Activity in Response to Aphidicolin Treatment. Mutat Res. 2010, 686: 39-46. 10.1016/j.mrfmmm.2009.12.012PubMed CentralView ArticlePubMed
- Arlt MF, Xu B, Durkin SG, Casper AM, Kastan MB, Glover TW: BRCA1 Is Required for Common-Fragile-Site Stability via Its G2/M Checkpoint Function. Mol Cell Biol. 2004, 24: 6701-6709. 10.1128/MCB.24.15.6701-6709.2004PubMed CentralView ArticlePubMed
- Musio A, Montagna C, Mariani T, Tilenni M, Focarelli ML, Brait L, Indino E, Benedetti PA, Chessa L, Albertini A: SMC1 involvement in fragile site expression. Hum Mol Genet. 2005, 14: 525-533.View ArticlePubMed
- Howlett NG, Taniguchi T, Durkin SG, D'Andrea AD, Glover TW: The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum Mol Genet. 2005, 14: 693-701. 10.1093/hmg/ddi065View ArticlePubMed
- Zhang H, Freudenreich CH: An AT-rich sequence in human common fragile site FRA16D causes fork stalling and chromosome breakage in S. cerevisiae. Mol Cell. 2007, 27: 367-379. 10.1016/j.molcel.2007.06.012PubMed CentralView ArticlePubMed
- Sharma S: Non-B DNA Secondary Structures and Their Resolution by RecQ Helicases. J Nucleic Acids. 2011, 2011: 724215-PubMed CentralView ArticlePubMed
- Sharma S, Doherty KM, Brosh RM: Mechanisms of RecQ helicases in pathways of DNA metabolism and maintenance of genomic stability. Biochem J. 2006, 398: 319-337. 10.1042/BJ20060450PubMed CentralView ArticlePubMed
- Budzowska M, Kanaar R: Mechanisms of dealing with DNA damage-induced replication problems. Cell Biochem Biophys. 2009, 53: 17-31. 10.1007/s12013-008-9039-yView ArticlePubMed
- Li L, Zou L: Sensing, signaling, and responding to DNA damage: organization of the checkpoint pathways in mammalian cells. J Cell Biochem. 2005, 94: 298-306. 10.1002/jcb.20355View ArticlePubMed
- Schwartz M, Zlotorynski E, Goldberg M, Ozeri E, Rahat A, le Sage C, Chen BP, Chen DJ, Agami R, Kerem B: Homologous recombination and nonhomologous end-joining repair pathways regulate fragile site stability. Genes Dev. 2005, 19: 2715-2726. 10.1101/gad.340905PubMed CentralView ArticlePubMed
- Moynahan ME, Jasin M: Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat Rev Mol Cell Biol. 2010, 11: 196-207. 10.1038/nrm2851PubMed CentralView ArticlePubMed
- Petermann E, Helleday T: Pathways of mammalian replication fork restart. Nat Rev Mol Cell Biol. 2010, 11: 683-687. 10.1038/nrm2974View ArticlePubMed
- Dillon LW, Burrow AA, Wang YH: DNA instability at chromosomal fragile sites in cancer. Curr Genomics. 2010, 11: 326-337. 10.2174/138920210791616699PubMed CentralView ArticlePubMed
- Palakodeti A, Han Y, Jiang Y, Le Beau MM: The role of late/slow replication of the FRA16D in common fragile site induction. Genes Chromosomes Cancer. 2004, 39: 71-76. 10.1002/gcc.10290View ArticlePubMed
- Letessier A, Millot GA, Koundrioukoff S, Lachages A-M, Vogt N, Hansen RS, Malfoy B, Brison O, Debatisse M: Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site. Nature. 2011, 470: 120-123. 10.1038/nature09745View ArticlePubMed
- Ozeri-Galai E, Lebofsky R, Rahat A, Bester Assaf C, Bensimon A, Kerem B: Failure of Origin Activation in Response to Fork Stalling Leads to Chromosomal Instability at Fragile Sites. Mol Cell. 2011, 43: 122-131. 10.1016/j.molcel.2011.05.019View ArticlePubMed
- Berti M, Chaudhuri AR, Thangavel S, Gomathinayagam S, Kenig S, Vujanovic M, Odreman F, Glatter T, Graziano S, Mendoza-Maldonado R: Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibition. Nat Struct Mol Biol. 2013, 20: 347-354. 10.1038/nsmb.2501PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.